Skip to main content

Find Clinical Trials

Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Service de médecine interne, hôpital Purpan, place du Dr Baylac Toulouse, France

View Trial Details

Completed

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

NCT00012350

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Radioimmunoimaging of AL Amyloidosis

NCT01409148

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

NCT00003143

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

NCT00920855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Pacific Oncololgy & Hematology Encinitas, California, United States

Capitol Hematology Oncology Roseville, California, United States

University Of California, San Diego San Diego, California, United States

James R. Berenson, M.D., Inc. West Hollywood, California, United States

View all 13 locations

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

CI-994 in Treating Patients With Advanced Myeloma

NCT00005624

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions: Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations: CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Centre Hospitalier Universitaire Henri Mondor Créteil, France

Hopital Edouard Herriot - Lyon Lyon, France

Hopital Saint-Louis Paris, France

View all 13 locations

View Trial Details